Research Papers

13 of 388 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Hepatocellular adenoma: when and how to treat? Update of current evidence.
Thomeer MG; Broker M; Verheij J; Doukas M; Terkivatan T; Bijdevaate D; De Man RA; Moelker A; IJzermans JN.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer.
Liu X; Yang Z; Latchoumanin O; Qiao L.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhot…
Ventura-Cots M; Concepción M; Arranz JA; Simón-Talero M; Torrens M; Blanco-Grau A; Fuentes I; Suñé P; Alvarado-Tapias E; Gely C; Roman E; Mínguez B; Soriano G; Genescà J; Córdoba J.
Therap Adv Gastroenterol (Unknown)
Published: 2016
3/6 Transparent
Registered Funding Declared
The location of obstruction predicts stent occlusion in malignant gastric outlet obstruction.
Grunwald D; Cohen J; Bartley A; Sheridan J; Chuttani R; Sawhney MS; Pleskow DK; Berzin TM; Mizrahi M.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.
Araujo JL; Altorki NK; Sonett JR; Rodriguez A; Sungur-Stasik K; Spinelli CF; Neugut AI; Abrams JA.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Usefulness of spectral computed tomography for evaluation of intestinal activity and severity in ileocolonic Crohn's di…
Peng JC; Feng Q; Zhu J; Shen J; Qiao YQ; Xu JR; Ran ZH.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systemat…
Afonso J; Lopes S; Gonçalves R; Caldeira P; Lago P; Tavares de Sousa H; Ramos J; Gonçalves AR; Ministro P; Rosa I; Vieira AI; Coelho R; Tavares P; Soares J; Sousa AL; Carvalho D; Sousa P; da Silva JP; Meira T; Silva Ferreira F; Dias CC; Chowers Y; Ben-Horin S; Magro F; on behalf Portuguese IBD Study Group (GEDII).
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disin…
Kukulka M; Nudurupati S; Perez MC.
Therap Adv Gastroenterol (Unknown)
Published: 2016
3/6 Transparent
Registered Funding Declared
Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole.
Kukulka M; Nudurupati S; Perez MC.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
The mucosal microbiota in a young child with severe non-Helicobacter gastritis.
Preidis GA; Luna RA; Hollister EB; Schady D; Gao C; Finegold MJ; Versalovic J; Shulman RJ.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experienc…
Fukuda D; Akazawa Y; Takeshima F; Nakao K; Fukuda Y.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Placement of a 6 mm, fully covered metal stent for main pancreatic head duct stricture due to chronic pancreatitis: a p…
Ogura T; Onda S; Takagi W; Kitano M; Sano T; Okuda A; Miyano A; Masuda D; Takeuchi T; Fukunishi S; Higuchi K.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Closure of gastrointestinal defects with Ovesco clip: long-term results and clinical implications.
Donatelli G; Cereatti F; Dhumane P; Vergeau BM; Tuszynski T; Marie C; Dumont JL; Meduri B.
Therap Adv Gastroenterol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared